The first question answered by the court was whether the expression "known substance" in section 3(d) is confined to pharmaceutical substances, as argued by Novozymes. After careful analysis of relevant paragraphs of the Division bench judgement in the Novartis matter and in the Supreme court judgment, the court held that it does not follow from the two decisions that the provision only applies to pharmaceutical and agro-chemical substances and not to biochemical substances.